Skip to main content
Biophysical Reviews logoLink to Biophysical Reviews
. 2017 Dec 18;10(2):255–258. doi: 10.1007/s12551-017-0361-8

Heat denaturation of the antibody, a multi-domain protein

Yoko Akazawa-Ogawa 1, Hidenori Nagai 1,2, Yoshihisa Hagihara 1,
PMCID: PMC5899721  PMID: 29256117

Abstract

The antibody is one of the most well-studied multi-domain proteins because of its abundance and physiological importance. In this article, we describe the effect of the complex, multi-domain structure of the antibody on its denaturation by heat. Natural antibodies are composed of 6 to 70 immunoglobulin fold domains, and are irreversibly denatured at high temperatures. Although the separated single immunoglobulin fold domain can be refolded after heat denaturation, denaturation of pairs of such domains is irreversible. Each antibody subclass exhibits a distinct heat tolerance, and IgE is especially known to be heat-labile. IgE starts unfolding at a lower temperature compared to other antibodies, because of the low stability of its CH3 domain. Each immunoglobulin domain starts unfolding at different temperatures. For instance, the CH3 domain of IgG unfolds at a higher temperature than its CH2 domain. Thus, the antibody has a mixture of folded and unfolded structures at a certain temperature. Co-existence of these folded and unfolded domains in a single polypeptide chain may increase the tendency to aggregate which causes the inactivation of the antibody.

Keywords: Antibody, Heat denaturation, Aggregation, Protein stability, Single-domain antibody

Introduction

Mammalian antibodies usually consist of multiple immunoglobulin fold domains; for instance, IgE and IgG have 14 and 12 domains, respectively (Fig. 1). Although VH and VL domains are sufficient to bind antigens, there are several artificial and smaller antibody formats, such as Fab and single-chain Fv that possess four and two domains, respectively. The camelid heavy-chain antibody that naturally lacks the light-chain and CH1 domain is half the size of an IgG. It consists of six domains and a separated VH domain, known as VHH, which can bind to an antigen with a single domain. In addition to the complexity of the overall structure and the number of domains, the differences in intra- and inter-domain interactions, which is determined by the amino acid sequences, give a distinct physical character to each antibody format. In this article, we compare the heat denaturation in several antibody formats and discuss the mechanism of heat denaturation of the antibody at the domain level.

Fig. 1.

Fig. 1

The domain structure of IgG, IgE, and heavy-chain antibody. Heavy and light chains are shown in white and black, respectively. The ovals indicate the domain composing the antibody and the names of domains are shown inside. The Fv, VHH, Fab, and Fc regions are indicated by thick, thin, dotted, and broken lines, respectively. The Fv with an artificial polypeptide linker between VH and VL domains is known as single-chain Fv

Heat-induced denaturation of IgG

IgG denaturation becomes significantly irreversible at temperatures higher than 65 °C (Mainer et al. 1999; Indyk et al. 2008). IgG almost completely loses its antigen-binding activity after heat treatment for several minutes at 90 °C (Augener and Grey 1970; van der Linden et al. 1999; Ladenson et al. 2006; Akazawa-Ogawa et al. 2014). Other classes of antibodies, such as IgA and IgM, are more sensitive to heat treatment than IgG. At 72 °C, IgG, IgA, and IgM in bovine milk are denatured by more than 75% after incubating for 25, 5, and 1.5 min, respectively (Mainer et al. 1997).

A series of heat-induced denaturation experiments have been carried out, mainly by using differential scanning calorimetry (DSC) to elucidate the mechanism of IgG denaturation (Vermeer and Norde 2000; Vermeer et al. 2000; Garber and Demarest 2007; Brader et al. 2015). Since heat-induced denaturation of IgG is irreversible in most cases, it is impossible to precisely analyze DSC data. However, the data allow us to compare the relative stability of domains in a single IgG, and those in different IgGs when the experimental condition is identical. Two or three distinct heat absorption peaks are observed in the DSC experiment with an increase in temperature, and each peak corresponds to a cooperative structural unit. After the analysis of isolated Fab and Fc regions from IgG by papain digestion, it was observed that Fab was less stable than Fc, and that heat denaturation of isolated Fc was irreversible (Augener and Grey 1970; Vermeer et al. 2000). Isolated Fab was also irreversibly denatured by heat (Deutscher et al. 1996). Later, it was found that Fc is not a cooperative unit, and that CH2 and CH3 were denatured independently. CH2 is the least stable cooperative structural unit in IgG (Feige et al. 2004; Chen et al. 2016). The interaction between carbohydrate chains and proteins enhances the stability of CH2 (Ghirlando et al. 1999; Voynov et al. 2009; Zheng et al. 2011). On the other hand, CH3 is the most stable structural unit (Demarest et al. 2004). Thus, the DSC experiment involving IgG shows three heat absorption peaks and the order of peak formation is usually CH2, Fab, and CH3, from low to high temperature. However, the peaks sometimes overlap and the order of the peaks may change depending on the stability of Fab and the subclass of IgG (Ito and Tsumoto 2013; Brader et al. 2015).

The heat-induced denaturation of isolated single CL, CH2, and CH3 domains is reversible at a neutral pH (Hagihara et al. 2002; Demarest et al. 2004; Feige et al. 2004). Thus, these isolated domains are considered to be highly heat resistant (i.e. doesn't aggregate). The heat denaturations of VH and VL are generally irreversible, although there is a naturally occurring VH domain that is heat-resistant and that refolds after heat denaturation (Jespers et al. 2004b). Mutation and acidic pH dramatically improve the heat resistance of VL and VL (Martsev et al. 2000; Jespers et al. 2004a; Hagihara et al. 2005). The isolated CH1 domain of murine IgG1 is disordered; it can form a structure only with the CL domain (Feige et al. 2009).

Recently, our group compared the heat resistance of murine IgG, Fab, single-chain Fv, and llama VHH (Akazawa-Ogawa et al. 2014). Each protein was subjected to repetitive 5-min incubation cycles at 90 °C and 20 °C. Additionally, the effect of continuous incubation at 90 °C was examined. With an increase in the number of cycles or incubation time at 90 °C, the residual antigen-binding activity at 20 °C decreased. After five cycles of incubation at 90 °C and 20 °C, and a corresponding total incubation of 25 min at 90 °C, the residual activity of the three IgGs that were examined were less than 10% of untreated proteins. Although the Fab domains of those IgGs were slightly more stable than those of IgG, less than 10% of residual activity was observed in these Fabs after ten cycles of heat treatment. The single-chain Fv exhibited higher heat resistance than IgG and Fab, where approximately half the activity was observed after one cycle of heat treatment. Forty cycles or 200 min of continuous incubation at 90 °C were required to inactivate a single-chain Fv exhibiting less than 10% of the original activity. The heat-induced inactivation of single-chain Fv was concentration-dependent and, thus, caused by aggregation of proteins, as expected, in other larger antibody formats. VHH exhibited significantly greater resistance towards repetitive and continuous heat treatments than any other antibody format. Even after 40 cycles of heat treatment corresponding to 200 min of incubation at 90 °C, approximately half of the original antigen-binding activity was retained. We found that inactivation of VHH under a long period of incubation at a high temperature is not caused by aggregation, but by chemical modification of asparagine and cystine (Akazawa-Ogawa et al. 2014, 2016).

Heat-induced irreversible denaturation of IgG has been utilized to prevent nonspecific polymerase chain reaction (PCR) (Kellogg et al. 1994; Sharkey et al. 1994; Mizuguchi et al. 1999). At the very first step of PCR, the temperature is increased from room temperature to DNA denaturing temperature around 95 °C. In this process, mismatched PCR templates remain and cause a nonspecific PCR product. Monoclonal antibody neutralizing thermostable DNA polymerase activity keeps inhibiting the PCR at low temperature where the mismatched PCR template is formed. At DNA denaturing temperature, the antibody is irreversibly denatured and does not disturb the amplification of DNA after the first ramp of the temperature. The antibodies against a number of DNA polymerases have been produced and commercialized.

The mechanism enabling lower stability in IgE than that in IgG

IgE has been known to be more heat-labile than other antibodies (Ishizaka et al. 1967). The incubation of IgE at 56 °C for a few hours significantly reduces anaphylactic activity, triggered by the binding of Fc of IgE to the Fcε receptor, but does not have a notable effect on the antigen-binding activity in the Fab region (Prouvost-Danon et al. 1977; Binaghi and Demeulemester 1983; Ishizaka et al. 1986). Under the same experimental conditions, anaphylactic IgG (IgG2a) did not lose its activity (Bloch et al. 1968), indicating the difference in heat resistance between the Fc domains of IgE and IgG. After DSC scanning, carried out from 10 to 90 °C, both the Fc domains of IgE and IgG were irreversibly denatured (Demarest et al. 2006).

The Fc of IgE is composed of one pair each of three heavy chain domains, CH2, CH3, and CH4. The Fcε receptor binds to the homodimeric interface of CH3 domains; CH2 and CH4 do not directly participate in the antibody–receptor interaction (Holdom et al. 2011). The Fc of IgE starts unfolding at a temperature approximately 15 °C lower than that of the Fc of IgG in the DSC experiment at a neutral pH (Demarest et al. 2006). The first phase of heat absorption in the Fc of IgE corresponds to the unfolding of CH3 and CH4, and the second phase corresponds to the unfolding of CH2. CH3 and CH4 are cooperatively unfolded as a single structural unit. Although the isolated CH3–CH4 construct is active and has a well-defined structure (Wurzburg et al. 2000; Hunt et al. 2005), isolated single-domain CH3 produced by E. coli exhibited weak receptor-binding activity and was partially unfolded (Henry et al. 2000). These findings indicate that the interaction between CH3 and CH4 is indispensable for maintaining the structure of CH3. The low heat resistance of anaphylactic IgE can be explained by the intrinsically low stability of the structural unit composed of CH3 and CH4.

Conclusions

Isolated domains in antibodies, such as VHH, CL, CH2, and CH3 in IgG, can be refolded after heat denaturation and are, thus, considered to be highly heat-resistant. Single-domain VHH has a low tendency to aggregate when denatured by heat. Additionally, the heat denaturation in homodimeric CH3 of IgG is reversible. On the other hand, the hetero-pairing of two different domains apparently reduces its heat resistance, as revealed by the inactivation of Fc after heat denaturation. Thus, the heat resistance of an antibody format might be restricted by formation-related interactions between two or more different domains. The intrinsic stability of each domain in the antibody format is different; thus, some domains are folded, while others are unfolded at a certain temperature. Fc of IgE is inactivated at 56 °C, whereas IgG remains active at that temperature. CH3 and CH4 of IgE unfold at a lower temperature than that of CH3 of IgG, although the CH2s of both antibody subtypes start unfolding at a similar temperature. At 56 °C, the structure of Fc of IgE is a mixture of folded and unfolded parts, while the Fc of IgG is completely folded. The inactivation of an antibody format with more than two domains is often caused by aggregation. These suggest that the co-existence of folded and unfolded domains in a single polypeptide chain increases the tendency to aggregate and causes the inactivation of the antibody format.

Compliance with ethical standards

Conflict of interest

Yoko Akazawa-Ogawa declares that she has no conflict of interest. Hidenori Nagai declares that he has no conflict of interest. Yoshihisa Hagihara declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Footnotes

This article is part of a Special Issue on ‘Biomolecules to Bio-nanomachines - Fumio Arisaka 70th Birthday’ edited by Damien Hall, Junichi Takagi and Haruki Nakamura.

References

  1. Akazawa-Ogawa Y, Takashima M, Lee YH, Ikegami T, Goto Y, Uegaki K, Hagihara Y. Heat-induced irreversible denaturation of the camelid single domain VHH antibody is governed by chemical modifications. J Biol Chem. 2014;289:15666–15679. doi: 10.1074/jbc.M113.534222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akazawa-Ogawa Y, Uegaki K, Hagihara Y. The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies. J Biochem. 2016;159:111–121. doi: 10.1093/jb/mvv082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Augener W, Grey HM. Studies on the mechanism of heat aggregation of human γG. J Immunol. 1970;105:1024–1030. [PubMed] [Google Scholar]
  4. Binaghi RA, Demeulemester C. Influence of the medium on the heat and acid denaturation of IgE. J Immunol Methods. 1983;65:225–233. doi: 10.1016/0022-1759(83)90319-8. [DOI] [PubMed] [Google Scholar]
  5. Bloch KJ, Morse HC, 3rd, Austen KF. Biologic properties of rat antibodies. I. Antigen-binding by four classes of anti-DNP antibodies. J Immunol. 1968;101:650–657. [PubMed] [Google Scholar]
  6. Brader ML, Estey T, Bai S, Alston RW, Lucas KK, Lantz S, Landsman P, Maloney KM. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies. Mol Pharm. 2015;12:1005–1017. doi: 10.1021/mp400666b. [DOI] [PubMed] [Google Scholar]
  7. Chen W, Kong L, Connelly S, Dendle JM, Liu Y, Wilson IA, Powers ET, Kelly JW. Stabilizing the CH2 domain of an antibody by engineering in an enhanced aromatic sequon. ACS Chem Biol. 2016;11:1852–1861. doi: 10.1021/acschembio.5b01035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Demarest SJ, Rogers J, Hansen G. Optimization of the antibody C(H)3 domain by residue frequency analysis of IgG sequences. J Mol Biol. 2004;335:41–48. doi: 10.1016/j.jmb.2003.10.040. [DOI] [PubMed] [Google Scholar]
  9. Demarest SJ, Hopp J, Chung J, Hathaway K, Mertsching E, Cao X, George J, Miatkowski K, LaBarre MJ, Shields M, Kehry MR. An intermediate pH unfolding transition abrogates the ability of IgE to interact with its high affinity receptor FcεRIα. J Biol Chem. 2006;281:30755–30767. doi: 10.1074/jbc.M605190200. [DOI] [PubMed] [Google Scholar]
  10. Deutscher SL, Crider ME, Ringbauer JA, Komissarov AA, Quinn TP. Stability studies of nucleic acid-binding Fab isolated from combinatorial bacteriophage display libraries. Arch Biochem Biophys. 1996;333:207–213. doi: 10.1006/abbi.1996.0382. [DOI] [PubMed] [Google Scholar]
  11. Feige MJ, Walter S, Buchner J. Folding mechanism of the CH2 antibody domain. J Mol Biol. 2004;344:107–118. doi: 10.1016/j.jmb.2004.09.033. [DOI] [PubMed] [Google Scholar]
  12. Feige MJ, Groscurth S, Marcinowski M, Shimizu Y, Kessler H, Hendershot LM, Buchner J. An unfolded CH1 domain controls the assembly and secretion of IgG antibodies. Mol Cell. 2009;34:569–579. doi: 10.1016/j.molcel.2009.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Garber E, Demarest SJ. A broad range of Fab stabilities within a host of therapeutic IgGs. Biochem Biophys Res Commun. 2007;355:751–757. doi: 10.1016/j.bbrc.2007.02.042. [DOI] [PubMed] [Google Scholar]
  14. Ghirlando R, Lund J, Goodall M, Jefferis R. Glycosylation of human IgG-fc: influences on structure revealed by differential scanning micro-calorimetry. Immunol Lett. 1999;68:47–52. doi: 10.1016/S0165-2478(99)00029-2. [DOI] [PubMed] [Google Scholar]
  15. Hagihara Y, Shiraki K, Nakamura T, Uegaki K, Takagi M, Imanaka T, Yumoto N. Screening for stable mutants with amino acid pairs substituted for the disulfide bond between residues 14 and 38 of bovine pancreatic trypsin inhibitor (BPTI) J Biol Chem. 2002;277:51043–51048. doi: 10.1074/jbc.M208893200. [DOI] [PubMed] [Google Scholar]
  16. Hagihara Y, Matsuda T, Yumoto N. Cellular quality control screening to identify amino acid pairs for substituting the disulfide bonds in immunoglobulin fold domains. J Biol Chem. 2005;280:24752–24758. doi: 10.1074/jbc.M503963200. [DOI] [PubMed] [Google Scholar]
  17. Henry AJ, McDonnell JM, Ghirlando R, Sutton BJ, Gould HJ. Conformation of the isolated Cε3 domain of IgE and its complex with the high-affinity receptor, FcεRI. Biochemistry. 2000;39:7406–7413. doi: 10.1021/bi9928391. [DOI] [PubMed] [Google Scholar]
  18. Holdom MD, Davies AM, Nettleship JE, Bagby SC, Dhaliwal B, Girardi E, Hunt J, Gould HJ, Beavil AJ, McDonnell JM, Owens RJ, Sutton BJ. Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcεRI. Nat Struct Mol Biol. 2011;18:571–576. doi: 10.1038/nsmb.2044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hunt J, Beavil RL, Calvert RA, Gould HJ, Sutton BJ, Beavil AJ. Disulfide linkage controls the affinity and stoichiometry of IgE Fcε3–4 binding to FcεRI. J Biol Chem. 2005;280:16808–16814. doi: 10.1074/jbc.M500965200. [DOI] [PubMed] [Google Scholar]
  20. Indyk HE, Williams JW, Patel HA. Analysis of denaturation of bovine IgG by heat and high pressure using an optical biosensor. Int Dairy J. 2008;18:359–366. doi: 10.1016/j.idairyj.2007.10.004. [DOI] [Google Scholar]
  21. Ishizaka K, Ishizaka T, Menzel AE. Physicochemical properties of reaginic antibody. VI. Effect of heat on gamma-E-, gamma-G- and gamma-A-antibodies in the sera of ragweed sensitive patients. J Immunol. 1967;99:610–618. [PubMed] [Google Scholar]
  22. Ishizaka T, Helm B, Hakimi J, Niebyl J, Ishizaka K, Gould H. Biological properties of a recombinant human immunoglobulin epsilon-chain fragment. Proc Natl Acad Sci U S A. 1986;83:8323–8327. doi: 10.1073/pnas.83.21.8323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ito T, Tsumoto K. Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress. Protein Sci. 2013;22:1542–1551. doi: 10.1002/pro.2340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jespers L, Schon O, Famm K, Winter G. Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol. 2004;22:1161–1165. doi: 10.1038/nbt1000. [DOI] [PubMed] [Google Scholar]
  25. Jespers L, Schon O, James LC, Veprintsev D, Winter G. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. J Mol Biol. 2004;337:893–903. doi: 10.1016/j.jmb.2004.02.013. [DOI] [PubMed] [Google Scholar]
  26. Kellogg DE, Rybalkin I, Chen S, Mukhamedova N, Vlasik T, Siebert PD, Chenchik A. TaqStart Antibody: “hot start” PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. BioTechniques. 1994;16:1134–1137. [PubMed] [Google Scholar]
  27. Ladenson RC, Crimmins DL, Landt Y, Ladenson JH. Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment. Anal Chem. 2006;78:4501–4508. doi: 10.1021/ac058044j. [DOI] [PubMed] [Google Scholar]
  28. Mainer G, Sanchez L, Ena JM, Calvo M. Kinetic and thermodynamic parameters for heat denaturation of bovine milk IgG, IgA and IgM. J Food Sci. 1997;62:1034–1038. doi: 10.1111/j.1365-2621.1997.tb15032.x. [DOI] [Google Scholar]
  29. Mainer G, Domínguez E, Randrup M, Sánchez L, Calvo M. Effect of heat treatment on anti-rotavirus activity of bovine colostrum. J Dairy Res. 1999;66:131–137. doi: 10.1017/S0022029998003239. [DOI] [PubMed] [Google Scholar]
  30. Martsev SP, Chumanevich AA, Vlasov AP, Dubnovitsky AP, Tsybovsky YI, Deyev SM, Cozzi A, Arosio P, Kravchuk ZI. Antiferritin single-chain Fv fragment is a functional protein with properties of a partially structured state: comparison with the completely folded V(L) domain. Biochemistry. 2000;39:8047–8057. doi: 10.1021/bi992036d. [DOI] [PubMed] [Google Scholar]
  31. Mizuguchi H, Nakatsuji M, Fujiwara S, Takagi M, Imanaka T. Characterization and application to hot start PCR of neutralizing monoclonal antibodies against KOD DNA polymerase. J Biochem. 1999;126:762–768. doi: 10.1093/oxfordjournals.jbchem.a022514. [DOI] [PubMed] [Google Scholar]
  32. Prouvost-Danon A, Binaghi RA, Abadie A. Effect of heating at 56 °C on mouse IgE antibodies. Immunochemistry. 1977;14:81–84. doi: 10.1016/0019-2791(77)90284-1. [DOI] [PubMed] [Google Scholar]
  33. Sharkey DJ, Scalice ER, Christy KG, Atwood SM, Daiss JL. Antibodies as thermolabile switches: high temperature triggering for the polymerase chain reaction. Biotechnology. 1994;12:506–509. doi: 10.1038/nbt0594-506. [DOI] [PubMed] [Google Scholar]
  34. van der Linden RH, Frenken LG, de Geus B, Harmsen MM, Ruuls RC, Stok W, de Ron L, Wilson S, Davis P, Verrips CT. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta. 1999;1431:37–46. doi: 10.1016/S0167-4838(99)00030-8. [DOI] [PubMed] [Google Scholar]
  35. Vermeer AW, Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys J. 2000;78:394–404. doi: 10.1016/S0006-3495(00)76602-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vermeer AW, Norde W, van Amerongen A. The unfolding/denaturation of immunogammaglobulin of isotype 2b and its F(ab) and F(c) fragments. Biophys J. 2000;79:2150–2154. doi: 10.1016/S0006-3495(00)76462-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Voynov V, Chennamsetty N, Kayser V, Helk B, Forrer K, Zhang H, Fritsch C, Heine H, Trout BL. Dynamic fluctuations of protein–carbohydrate interactions promote protein aggregation. PLoS One. 2009;4:e8425. doi: 10.1371/journal.pone.0008425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wurzburg BA, Garman SC, Jardetzky TS. Structure of the human IgE-Fc Cε3-Cε4 reveals conformational flexibility in the antibody effector domains. Immunity. 2000;13:375–385. doi: 10.1016/S1074-7613(00)00037-6. [DOI] [PubMed] [Google Scholar]
  39. Zheng K, Bantog C, Bayer R. The impact of glycosylation on monoclonal antibody conformation and stability. MAbs. 2011;3:568–576. doi: 10.4161/mabs.3.6.17922. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biophysical Reviews are provided here courtesy of Springer

RESOURCES